Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.
| Image |  |
|---|---|
| Description | scientific article published on 6 July 2017 |
| Author/s |
author: Christine Lebrun-Frenay Xavier Montalban Pierre Clavelou Santiago Pérez-Hoyos Clara Matute-Blanch Nicolás Miguel Fissolo |
| Publication date | July 22, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |